ASHLEY WICKS: Open Payments
NPI 1699052118 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,790 in 97 payments from 20 companies in 2025. Trend: 2023 $2,107 · 2024 $2,019 · 2025 $1,790
Food & beverage: $1,790
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $332 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $234 |
| Neurocrine BioSciences, Inc. | 12 | $214 |
| Noven Therapeutics, LLC | 12 | $202 |
| Alkermes, Inc. | 5 | $119 |
| Janssen Pharmaceuticals, Inc | 5 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $86 |
| Vanda Pharmaceuticals Inc. | 2 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
Products named: VRAYLAR, TRINTELLIX, INGREZZA, Xelstrym, ARISTADA, SPRAVATO, REXULTI, CAPLYTA.
Industry payments across FL — which companies pay providers there.
